SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-18-008337
Filing Date
2018-06-27
Accepted
2018-06-27 16:16:35
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUATERLY REPORT f10q0318a1_converisonlabs.htm 10-Q/A 431378
2 CERTIFICATION f10q0318a1ex31-1_converison.htm EX-31.1 8963
3 CERTIFICATION f10q0318a1ex31-2_converison.htm EX-31.2 9185
4 CERTIFICATION f10q0318a1ex32-1_converison.htm EX-32.1 4119
5 CERTIFICATION f10q0318a1ex32-2_converison.htm EX-32.2 4159
  Complete submission text file 0001213900-18-008337.txt   4673549

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE immd-20180331.xml EX-101.INS 842366
7 XBRL SCHEMA FILE immd-20180331.xsd EX-101.SCH 49191
8 XBRL CALCULATION FILE immd-20180331_cal.xml EX-101.CAL 39465
9 XBRL LABEL FILE immd-20180331_lab.xml EX-101.LAB 518867
10 XBRL DEFINITION FILE immd-20180331_def.xml EX-101.DEF 250501
11 XBRL PRESENTATION FILE immd-20180331_pre.xml EX-101.PRE 365807
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
CONVERSION LABS, INC. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55857 | Film No.: 18921961
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1